A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of unripe Bokbunja Extract on decrease of body fat

Wonkwang University. Iksan Korean Medicine Hospital0 个研究点目标入组 140 人开始时间: 待定最近更新: 2021年7月12日

适应症

试验速览

暂无简介。

•1) 25 = BMI = 34.9 kg/m2 or 25%(male), 30%(female) =body fat percentage
•2) Participants who have fully understood information provided about the study, voluntarily decided to participate, and agreed to comply with precautions

•1) Participants who have had a weight change of 10% of more within the 3 months prior to the screening examination.
•2) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
•3) Fasteners
•4) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination.
•5) Participants who have participated in other interventional clinical trials within 3 months prior to the screening examination, or plan to participate in other interventional clinical trials.
•6) Participants who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.

发起方

Wonkwang University. Iksan Korean Medicine Hospital